Clinical trial
A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus…
NCT00265317 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00265317 |
|---|---|
| Title | A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib Alone |
| Official title | Randomized, Double-Blind, Phase 2 Study Of Erlotinib With Or Without SU011248 In The Treatment Of Metastatic Non-Small Cell Lung Cancer |
| Acronym | SUN1058 |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Non-Small-Cell Lung |
| Intervention type | Drug |
| Interventions | erlotinib, sunitinib, placebo |
| Enrollment | 162 |
| Start date | Jun 1, 2006 |
| Primary completion | Jan 1, 2010 |
| Completion | Jan 1, 2012 |
| First posted | Dec 14, 2005 |
| Last update posted | Feb 6, 2013 |
| Countries | Canada, Hungary, Italy, Netherlands, Poland, Romania, Spain, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: